{
    "symbol": "AUTL",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-08 03:59:04",
    "content": " Your line is open. Your line is open. Your line is open. And so, what we\u2019re doing with the MRD cohort is, alongside the dataset that we need to have in place to support the regulatory approval of the product, we are also looking to generate data that actually support and basically characterize the profile of the product, against patient, in patients with lower disease burden, which is closer to what actually we are seeing in many clinical practices, both in the U.S. and in Europe, the physicians moving to. Your line is open. Your line is open. Your line is open. Your line is open. Your line is open."
}